Showing results (311-320 of 352) with videos related to
Sort By:
Pageof 36
The Journal of Biological Chemistry|September 13, 2001
Polarized expression of G protein-coupled receptors and an all-or-none discharge of Ca2+ pools at initiation sites of [Ca2+]i waves in polarized exocrine cellsD M Shin, X Luo, T M Wilkie, et al.The Journal of Biological Chemistry|February 13, 1999
Structurally related peptide agonist, partial agonist, and antagonist occupy a similar binding pocket within the cholecystokinin receptor. Rapid analysis using fluorescent photoaffinity labeling probes and capillary electrophoresisM Dong, X Q Ding, D I Pinon, et al.The Journal of Biological Chemistry|October 26, 2000
Refinement of the structure of the ligand-occupied cholecystokinin receptor using a photolabile amino-terminal probeX Q Ding, V Dolu, E M Hadac, et al.The European Journal of Surgery = Acta Chirurgica|March 1, 1994
Complications during the introduction of laparoscopic cholecystectomy in Norway. A prospective multicentre study in seven hospitalsE Trondsen, T E Ruud, B H Nilsen, et al.The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|January 2, 2009
Spatial learning impairment, enhanced CDK5/p35 activity, and downregulation of NMDA receptor expression in transgenic mice expressing tau-tubulin kinase 1Shinji Sato, Jiqing Xu, Satoshi Okuyama, et al.Cancer Investigation|May 16, 2000
Interleukin-1 family expression in human breast cancer: interleukin-1 receptor antagonistL J Miller, S H Kurtzman, K Anderson, et al.The American Journal of Physiology|June 1, 1991
Abnormal gallbladder motility in irritable bowel syndrome: evidence for target-organ defectP S Kamath, H Y Gaisano, S F Phillips, et al.The Journal of Urology|June 1, 1997
Vascular endothelial growth factor (VEGF) expression in human prostate cancer: in situ and in vitro expression of VEGF by human prostate cancer cellsF A Ferrer, L J Miller, R I Andrawis, et al.The Journal of Biological Chemistry|July 20, 2001
Identification of peptide ligand-binding domains within the human motilin receptor using photoaffinity labelingB Coulie, B Matsuura, M Dong, et al.Journal of Medicinal Chemistry|January 6, 1995
CCK-A receptor selective antagonists derived from the CCK-A receptor selective tetrapeptide agonist Boc-Trp-Lys(Tac)-Asp-MePhe-NH2 (A-71623)E E Sugg, M J Kimery, J M Ding, et al.Pageof 36